(Q42050269)

15 October 2017

Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells (English)

1 reference

15 October 2017

1 reference

Bastian Schilling

1

1 reference

PMC publication ID

3805652

15 October 2017

Annette Paschen

series ordinal

2

1 reference

15 October 2017

10 June 2013

1 reference

15 October 2017

1 reference

15 October 2017

2

1 reference

15 October 2017

8

1 reference

15 October 2017

e25218

1 reference

Hepatotoxicity with combination of vemurafenib and ipilimumab

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Update on the targeted therapy of melanoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Melanoma-induced immunosuppression and its neutralization

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Human T cell responses against melanoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805652

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24167759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.25218

1 reference

15 October 2017

1 reference

PMC publication ID

3805652

15 October 2017

PubMed publication ID

24167759

1 reference

PMC publication ID

3805652